Sodium F-Fluoride PET/CT of Bone, Joint, and Other Disorders

The use of 18F-sodium fluoride (18F-NaF) with PET/CT is increasing. This resurgence of an old tracer has been fueled by several factors including superior diagnostic performance over standard 99mTc-based bone scintigraphy, growth in the availability of PET/CT imaging systems, increase in the number of regional commercial distribution centers for PET radiotracers, the recent concerns about potential recurring shortages with 99mTc-based radiotracers, and the recent decision by the Centers for Medicare and Medicaid Services to reimburse for 18F-NaF PET/CT for evaluation of patients with known or suspected bone metastases through the National Oncologic PET Registry.
Source: Seminars in Nuclear Medicine - Category: Radiology Authors: Source Type: research